Glycomet is a drug that is also called Biguanide. It’s a hypoglycemic agent that reduces the concentration of glucose in the blood by suppressing gluconeogenesis in the liver, reducing the absorption of glucose from the digestive tract, and increasing its utilization in tissues in patients with diabetes mellitus. The drug reduces the concentration of Thyroglobulin, cholesterol, and LDL (determined on an empty stomach) in the blood serum and does not change the concentration of lipoproteins of other densities. Glycomet stabilizes or reduces body weight. The pills don’t cause hypoglycemic reactions and improve the fibrinolytic properties of the blood.
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Glycomet is a generic powerful medication that is used mostly to control the levels of glucose in patients suffering from diabetes type II.
Usually, a great deal of those who suffer from this disease may significantly decrease the most hazardous risks if they start dieting. In those cases when the alimentary therapeutics proves itself inefficient, it is essential to use the blocking agent present in the drug’s composition to achieve reliable control.
By decreasing the amount of the released sugar, the medicinal product simultaneously lowers your appetite and lowers the cholesterol levels. Thanks to this effect, this pharmaceutical substance is effectively used as an additional component in the insulin therapy of diabetes type I in patients with excess weight.
The following illnesses and conditions must be considered a reason to avoid treatment with the medication:
- hypersensitivity to the components of the medication;
- renal dysfunction;
- cardiac or respiratory failure;
- pulmonary diseases;
- moderate hepatic impairment;
- severe infectious diseases;
- dehydration caused by severe diarrhea or vomiting;
- all conditions associated with hypoxia;
- renal infections.
- The duration of the treatment is determined depending on the severity of the illness, your tolerability, and your body weight.
- The dose of the drug is calculated by the professional therapists for each patient, depending on the level of glucose.
- The starting dose for adults is 500-1.000 mg/day. After 10-15 days, it may be increased based on the statistically correct assumption that the potential for further medical activities requires more intensive therapy.
- In order to reduce the possibility of hazardous outcomes, the daily dose should be divided into two-three less powerful doses.
- The maintenance dose of the drug is usually 1.500-2.000 mg/day. The maximal allowed dose must not exceed 3.000 mg/day.
Following the prescription proposed by the primary care doctor will allow you to avoid most of the frequently occurred negative reactions that may be expected when using the medicine. Common negative reactions include nausea, a noticeable lack of appetite, vomiting, diarrhea of different origin, abdominal pain, and headache. These symptoms occur especially at the beginning of treatment and, as a rule, disappear on their own.
Patients over the age of sixty who perform heavy physical work also must avoid taking this medication because its use under these conditions may lead to the development of the lactic acidosis.
Rare negative reactions include rashes, itching, and acute chest pain.
Undesired effects connected with various metabolic disorders include diathesis (requires the immediate discontinuation of the therapy) and hypovitaminosis B12, which usually occurs as the result of the prolonged treatment.
Some of the additional symptoms may develop as a result of the drug’s interaction with alcohol, more precisely moderate muscle pain, prolonged periods of weakness, dizziness, or difficulty sleeping. Stop drinking while using the medication and report to your physician the moment you detect one of these symptoms to avoid dangerous effects.